Advertisement

Rheumatology International

, Volume 21, Issue 6, pp 222–226 | Cite as

Fcγ receptor IIIA polymorphism in Korean patients with systemic lupus erythematosus

  • Eun Lee
  • Yun Lee
  • Han Baek
  • Seong Kang
  • Eun Chung
  • Chang Shin
  • Kyeong Hong
  • Betty P. Tsao
  • Bevra H. Hahn
  • Yeong Song
Original Article

Abstract.

Systemic lupus erythematosus (SLE) is characterized by the presence of various autoantibodies and the deposition of immune complex, which is cleared by Fcγ receptors. Genotype analysis was done to investigate whether the FcγRIIIA-176F/V polymorphism is a risk factor for SLE in Koreans. We genotyped 145 Korean SLE patients and 75 control subjects for FcγRIIIA-176F/V. After amplifying a 1.7-kb fragment containing the FcγRIIIA-176F/V polymorphic site using two FcγRIIIA gene-specific primers, we performed a nested polymerase chain reaction (PCR) for allele-specific genotyping at position 559 in FcγRIIIA. FcγRIIIA genotype or allele distribution was not significantly different between lupus patients and controls, and also between lupus nephritis patients and healthy controls. Neither creatinine clearance, 24 h urine proteinuria, number of American College of Rheumatology (ACR) criteria, nor the Systemic Lupus International Collaborating Clinics (SLICC)/ACR damage index was different according to the genotype. In conclusion, FcγRIIIA-176F/V polymorphism is not associated with SLE in Koreans.

Systemic lupus erythematosus FcγR IIIA polymorphism Koreans Anti-double-stranded DNA 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag 2002

Authors and Affiliations

  • Eun Lee
    • 1
  • Yun Lee
    • 1
  • Han Baek
    • 1
  • Seong Kang
    • 1
  • Eun Chung
    • 1
  • Chang Shin
    • 2
  • Kyeong Hong
    • 2
  • Betty P. Tsao
    • 3
  • Bevra H. Hahn
    • 3
  • Yeong Song
    • 1
  1. 1.Division of Rheumatology, Department of Internal Medicine, Clinical Research Institute, Seoul National University College of Medicine, Seoul, KoreaKorea
  2. 2.Department of Biochemistry, Wonkwang University, Iksan, KoreaKorea
  3. 3.University of California at Los Angeles Medical Center, Los Angeles, Calif., USAUSA

Personalised recommendations